Dr Stuart Onions has over 15 years drug discovery experience. He has held a variety of positions at Sygnature Discovery...
View Article
Dr Stuart Onions has over 15 years drug discovery experience. He has held a variety of positions at Sygnature Discovery...
View Article
John joined Sygnature in August 2011 from AstraZeneca to establish and lead the Bioscience group. Under his leadership, that department...
View Article
Geraint joined the company in September 2005 and has 13 years of drug discovery experience gained in biotechnology companies and...
View Article
Iain joined Sygnature in January 2011 from an Associate Principal Scientist role at AstraZeneca Charnwood, where he worked for 17...
View Article
Colin joined Sygnature in May 2012 to take on a newly-created role to manage computational science and informatics at Sygnature....
View Article
Joined Sygnature in September 2020 as Director and Head of Drug Abuse and Substance Use Disorders from Sosei Heptares. Andy has over 25...
View Article
Dr Steven Vickers joined Sygnature in July 2018, following the acquisition of RenaSci by Sygnature Discovery. Steven is an in...
View Article
Allan joined Sygnature Discovery in February 2019 and is Vice President of Oncology Drug Discovery. Allan has over 23 years...
View Article
Jane Kendrew joined Sygnature Discovery in June 2020 as Director of Translational Oncology. Jane has over 29 years drug discovery...
View Article
Meet Dave Pearson, the seasoned Director of Form and Formulation at Sygnature Discovery, leading the way with over 20 years of expertise in solid form and formulation science. From crystallinity to cGMP production, Dave optimizes molecules for clinic readiness. Discover how his vast experience drives success for clients and patients alike. PhD holder from the University of Sheffield, Dave bridges the gap between synthetic chemistry and patient-centric solutions
Stephen joined Sygnature in January 2016 from Hitgen where he was VP Business Development; establishing several early research collaborations for...
View Article
Max Mirza is a neuroscientist who has worked in biotech, big and midsize pharma for over 25 years. He has run...
View Article